Articles and Blogs

5/14/2026 UPDATE: On May 14, 2026, the U.S. Supreme Court extended a stay preserving telehealth access to mifepristone while the Fifth Circuit considers a challenge to regulations permitting pharmacies, including mail‑order pharmacies, to dispense the drug directly to patients. The order maintains the existing regulatory framework for mifepristone, allowing prescribing via telehealth and dispensing... READ MORE

On June 13, 2024, the Supreme Court of the United States unanimously rejected a challenge to the U.S. Food & Drug Administration (“FDA”) approval and regulation of mifepristone (brand name “Mifeprix”), a drug used in medically induced abortions. In a 9-0 decision delivered by Justice Brett Kavanaugh, the Supreme Court held that the plaintiffs,... READ MORE